Why isn't warfarin prescribed to patients with nonrheumatic atrial fibrillation?
about
The risk of hemorrhagic complications in hospital in-patients who fall while receiving antithrombotic therapyEffect of access to anticoagulation management services on warfarin use in patients with atrial fibrillationA community-based educational intervention to improve antithrombotic drug use in atrial fibrillationImproving stroke prevention therapy for patients with atrial fibrillation in primary care: protocol for a pragmatic, cluster-randomized trial.Erratum: utilization of anticoagulation therapy in medicare patients with nonvalvular atrial fibrillationRisk scores and geriatric profile: can they really help us in anticoagulation decision making among older patients suffering from atrial fibrillation?Characteristics affecting oral anticoagulant therapy choice among patients with non-valvular atrial fibrillation: a retrospective claims analysis.Atrial fibrillation and stroke: what we know, what's new, and what we should do now.Impact of stated barriers on proposed warfarin prescription for atrial fibrillation: a survey of Canadian physicians.Predictors of warfarin use in atrial fibrillation in the United States: a systematic review and meta-analysis.Could some geriatric characteristics hinder the prescription of anticoagulants in atrial fibrillation in the elderly?Impact of adverse events on prescribing warfarin in patients with atrial fibrillation: matched pair analysis.Bleeding Risk Index in an anticoagulation clinic. Assessment by indication and implications for careLeft Atrial Appendage Closure in Atrial Fibrillation: A World without Anticoagulation?A cluster-randomized controlled trial of a computerized antithrombotic risk assessment tool to optimize stroke prevention in general practice: a study protocol.Stroke and atrial fibrillation: is stroke prevention treatment appropriate beforehand? SAFE I Study Investigators.Stroke prevention and atrial fibrillation: reasons leading to an inappropriate management. Main results of the SAFE II study.Do physician outcome judgments and judgment biases contribute to inappropriate use of treatments? Study protocol.Anticoagulated patient's perception of their illness, their beliefs about the anticoagulant therapy prescribed and the relationship with adherence: impact of novel oral anticoagulant therapy - study protocol for The Switching Study: a prospective coThe risks of warfarin use in the elderly.Application of a decision support tool for anticoagulation in patients with non-valvular atrial fibrillationExamining warfarin underutilization rates in patients with atrial fibrillation: Detailed chart review essential to capture contraindications to warfarin therapy.Using Clinical Vignettes to Assess Quality of Care for Acute Respiratory InfectionsUsing an Atrial Fibrillation Decision Support Tool for Thromboprophylaxis in Atrial Fibrillation: Effect of Sex and Age.Variation in Anticoagulant Recommendations by the Guidelines and Decision Tools among Patients with Atrial Fibrillation.A non-experimental study of oral anticoagulation therapy initiation before and after national patient safety goals.Attitudes of physicians regarding anticoagulation for atrial fibrillation: a systematic review.Left atrial appendage exclusion for prevention of stroke in atrial fibrillation: review of minimally invasive approaches.Differences among geriatricians, general internists, and cardiologists in the care of patients with heart failure: a cautionary tale of quality assessment.Impact of Warfarin on Atrial-Fibrillation Outcomes Related to Economic Consumption Patterns: Hospitalization, Cost, and Mortality may be Predictable and Modifiable at the Population Level.Incidence and Determinants of Traumatic Intracranial Bleeding Among Older Veterans Receiving Warfarin for Atrial FibrillationEvaluating the Usability and Perceived Impact of an Electronic Medical Record Toolkit for Atrial Fibrillation Management in Primary Care: A Mixed-Methods Study Incorporating Human Factors Design.Quality Measures for Anticoagulation Care.The prestroke use of vitamin K antagonists for atrial fibrillation - trends over 15 years.Warfarin therapy for atrial fibrillation in the elderly.A pharmacokinetic study of the combined administration of amiodarone and ximelagatran, an oral direct thrombin inhibitor.[Atrial fibrillation, stroke and anticoagulation: under-use of warfarin?].Factors associated with undertreatment of atrial fibrillation in geriatric outpatients with Alzheimer disease.Physician decision making in anticoagulating atrial fibrillation: a prospective survey of a physician notification system for atrial fibrillation detected on cardiac implantable electronic devices of patients at increased risk of stroke.Patient-centered medical homes and oral anticoagulation therapy initiation.
P2860
Q24808679-D1FA10F4-294D-44F9-9FF7-F3B30E017334Q28192385-3749F138-25DE-4C4D-A647-267348C221FCQ28213965-CD633F50-65A6-4B83-84F9-F4C428745EA6Q30830699-45E0A38F-CF52-41C3-971D-9C9E9D82773BQ33714864-92CA21A8-2FF0-4319-8AF2-DC1BC17F5014Q33927278-E8CD4B48-C041-42CC-AE75-2DEAF4B98290Q33957383-6C3F4C58-593B-41CD-B9F7-2AFE05040415Q34025564-A732BBD6-2908-4C35-A2BC-8642DC97A967Q34087971-FCC6BA3F-6241-4675-AE60-3ED28998F03EQ34150474-7E456621-4DD0-4F58-8A87-8211B003B222Q34245296-C31E8C57-AA15-4CCB-B9D2-5F173DE08A85Q34276216-5E104687-E2A0-406E-89BD-0B11DC1CEF4EQ34724446-912040A5-1117-435B-9068-4C0FE93187FDQ34931005-4E1DD544-E9F6-4D37-AD27-97DEF57910DCQ35089113-836B0327-F46F-4F92-9C6D-B8BCF5D84FF5Q35566696-97DC6B04-8BBD-4A77-825E-8B0ED1EFA720Q35826197-B555545E-4F60-4ECD-86C2-975672E19426Q35855776-F702744D-294A-430F-8F61-D7E5BB247640Q36112493-0A147275-2099-4549-949F-DC37D938A914Q36446904-CCE231D5-ACE5-4E1A-BEF4-5B47C16C5D43Q36608284-975A9546-A9DE-491A-8D8F-98FBA3BDD996Q36755472-00ACA775-91AE-458A-B7A2-6764BAD791CEQ36824410-8F0576B0-C182-45B3-9AF0-11B9B34A1ABEQ36951700-6EFC6DD6-0284-4B6C-8CB3-49A21FBAE4FCQ37069287-9719423A-FA2E-46A0-8B6E-FC95496DA2CDQ37590855-773E8DED-EAB8-468E-8F9C-A414293D4412Q37912899-D9D0AECE-1E7A-4673-B846-91729CCB0534Q38177227-0677AEE4-230D-49F4-B3CD-EB41359CDF86Q39479491-2798F2E4-D30C-4BA9-A1D6-BA5EB23F0D9CQ39560667-0C4FBE50-E31D-4523-91A0-B15B4BF69FA7Q39581496-4309604B-5662-4068-9A4F-F886427F6D8EQ39631749-46A296E6-0EA5-4613-A9D5-355E937DFD39Q39697884-FFCF211B-DAB6-4F1C-B407-E0E159571354Q43533823-0774C02B-4CFA-4F6B-9AC2-A1518B05C862Q43888383-92A7F5BE-5BA8-4B6A-916A-EEF896FFC6F3Q45022899-AD2ED408-4D5D-4395-A3F8-B24F794DA132Q45194118-16E9540E-06C2-4DF9-B8DA-EB786B3E56D6Q46243568-7E6A1EC6-25A5-4B9C-BFC7-CF8FF17CBBDFQ50102698-443E34EC-7576-49E7-8D87-ADD22FA773C2Q51139933-45249E7F-75BA-43A9-BC9C-87A2FD924B8B
P2860
Why isn't warfarin prescribed to patients with nonrheumatic atrial fibrillation?
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
1996年论文
@zh
1996年论文
@zh-cn
name
Why isn't warfarin prescribed to patients with nonrheumatic atrial fibrillation?
@en
type
label
Why isn't warfarin prescribed to patients with nonrheumatic atrial fibrillation?
@en
prefLabel
Why isn't warfarin prescribed to patients with nonrheumatic atrial fibrillation?
@en
P2093
P2860
P356
P1476
Why isn't warfarin prescribed to patients with nonrheumatic atrial fibrillation?
@en
P2093
C S Landefeld
D G Miller
K E Covinsky
M R Antani
P2860
P2888
P304
P356
10.1007/BF02598985
P577
1996-12-01T00:00:00Z
P6179
1047098167